38I DCF Valuation - Intellia Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 11.62 EUR -1.36% Market Closed

Market Cap: €3.5B

I	Intellia Therapeutics Inc SWB:38I	US
K	KDDI Corp DUS:DIP	JP
R	Relx PLC AEX:REN	UK
	Twilio Inc LSE:0LHL	US
	Fujikura Ltd TSE:5803	JP
F	Fortune Brands Home & Security Inc LSE:0IRN	US
	F5 Inc NASDAQ:FFIV	US
	State Bank of India NSE:SBIN	IN
B	Beryl 8 Plus PCL SET:BE8	TH
E	EDP Renovaveis SA LSE:0ML1	ES
	Glencore PLC LSE:0IVW	CH
U	UPM-Kymmene Oyj SWB:RPL	FI
B	Bank of New York Mellon Corp DUS:BN9	US
G	Grindrod Ltd JSE:GNDP	ZA
	Lindsay Australia Ltd ASX:LAU	AU
G	General Dynamics Corp DUS:GDX	US
C	Colgate-Palmolive Co XETRA:CPA	US
A	Avaland Bhd KLSE:AVALAND	MY
B	Boston Beer Company Inc XBER:BBEA	US
A	American Water Works Company Inc LSE:0HEW	US
C	Cadence Design Systems Inc XBER:CDS	US
T	Thales SA XBER:CSF	FR
	Nongfu Spring Co Ltd OTC:NNFSF	CN
	Aegon NV MIL:1AGN	NL

38I's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.